Corporate News
Grifols SA, a Spanish specialty pharmaceutical company listed on the Madrid Stock Exchange, remained a notable holding for Spanish investors in 2025.
According to a broker‑led survey of 350,000 portfolios, Grifols was among the group of firms that attracted the most trading activity in the domestic market, alongside major banks and industrial groups. The analysis highlighted that while the broader investment landscape was dominated by interest in artificial‑intelligence themes, Grifols maintained a steady presence in investor attention. No further operational or financial developments for the company were reported in the available news items.
